pertussis
Information
- Disease name
- pertussis
- Disease ID
- DOID:1116
- Description
- "A commensal bacterial infectious disease that results_in inflammation located_in respiratory tract, has_material_basis_in Bordetella pertussis, or has_material_basis_in Bordetella parapertussis, which produce toxins that paralyze the cilia of the respiratory epithelial cells. The infection is characterized by a prolonged, high-pitched, deeply indrawn breath (whoop)." [url:http\://en.wikipedia.org/wiki/Pertussis, url:http\://www.merck.com/mmhe/sec23/ch272/ch272g.html#sec23-ch272-ch272g-800]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03147898 | Completed | Observational Study Describing the Immune Profile Induced By Pertussis Vaccines | April 12, 2017 | July 9, 2018 | |
| NCT00004799 | Completed | Phase 3 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines | April 1991 | |
| NCT00004800 | Completed | Phase 3 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines | September 1992 | |
| NCT00013871 | Completed | N/A | Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs | November 2004 | |
| NCT00092469 | Completed | Phase 3 | Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) | March 2002 | August 2003 |
| NCT00133445 | Completed | Phase 2 | Pentavalent DTaP-Hep B-IPV | December 2005 | August 2006 |
| NCT00138268 | Completed | Pilot Study Freeze and Transport Immune Cells | February 2005 | ||
| NCT00158808 | Completed | Phase 2 | Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths | January 2005 | April 2005 |
| NCT00168545 | Completed | Phase 4 | Immunology of Non-specific Effects of Vaccine | January 2006 | January 2007 |
| NCT00254917 | Completed | Phase 4 | Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines | October 2003 | February 2006 |
| NCT00254969 | Completed | Phase 3 | Immunogenicity and Safety of Pentaxim in South African Infants | October 2005 | January 2010 |
| NCT00255021 | Completed | Phase 4 | Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand | December 2005 | January 2009 |
| NCT00255047 | Completed | Phase 3 | Safety and Immune Response of Different Pediatric Combination Vaccines. | November 2005 | February 2009 |
| NCT00258882 | Completed | Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine | January 2006 | December 2012 | |
| NCT00258895 | Completed | Phase 3 | Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL® | March 2005 | April 2007 |
| NCT00258908 | Completed | Phase 3 | Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan | November 2005 | August 2006 |
| NCT00259337 | Completed | Phase 3 | Immunogenicity and Safety of Pentaxim™ in an Indian Population | February 2006 | December 2008 |
| NCT00287092 | Completed | Phase 3 | Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants | February 2006 | September 2008 |
| NCT00291967 | Completed | Phase 2 | Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants | November 2002 | |
| NCT00303316 | Completed | Phase 3 | Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants | February 2006 | September 2007 |
| NCT00304265 | Completed | Phase 4 | Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine | March 2006 | October 2007 |
| NCT00313911 | Completed | Phase 3 | Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. | July 2006 | February 2008 |
| NCT00315055 | Completed | Phase 3 | Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule | July 2006 | February 2008 |
| NCT00319553 | Completed | Phase 4 | Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® | May 2006 | December 2008 |
| NCT00319852 | Completed | Phase 3 | Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV | April 2006 | July 2008 |
| NCT02453048 | Completed | Phase 1 | Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine | September 2015 | December 2017 |
| NCT02458183 | Completed | Phase 3 | Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS | February 2, 2015 | May 5, 2018 |
| NCT02477995 | Completed | Phase 3 | Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants | December 2013 | July 2014 |
| NCT02526394 | Completed | Phase 4 | Pertussis and Meningitis C Concomitant Vaccination in Adolescents | September 2013 | March 31, 2017 |
| NCT02587520 | Completed | Phase 1/Phase 2 | Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects | October 22, 2015 | February 21, 2017 |
| NCT02759354 | Completed | Phase 3 | Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) | April 26, 2016 | August 1, 2016 |
| NCT02817451 | Completed | Phase 3 | DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants | July 14, 2016 | February 22, 2019 |
| NCT02858440 | Completed | Phase 3 | A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia | September 13, 2016 | November 13, 2018 |
| NCT02946190 | Completed | Phase 2 | The PertADO Geneva Trial | October 27, 2016 | March 9, 2017 |
| NCT00004422 | Completed | Phase 3 | Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection | August 1997 | September 2002 |
| NCT03208101 | Completed | Phase 1 | A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults | July 3, 2017 | December 21, 2017 |
| NCT03304275 | Completed | N/A | The Feasibility of Pertussis Immunization in a Canadian Emergency Department | July 10, 2017 | December 20, 2017 |
| NCT03498300 | Completed | Early Phase 1 | Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women | May 9, 2018 | April 13, 2019 |
| NCT03519373 | Completed | Pertussis Immunization During Pregnancy & HIV Infection | March 1, 2017 | June 1, 2019 | |
| NCT03541499 | Completed | Phase 2 | Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults | October 23, 2018 | May 15, 2020 |
| NCT03589768 | Completed | Phase 2 | Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants | January 24, 2019 | July 1, 2020 |
| NCT03697798 | Completed | Phase 4 | A Study Exploring Whooping Cough Protection in Children and Adults | April 18, 2018 | January 14, 2020 |
| NCT03870061 | Completed | N/A | Evaluation of an Infant Immunization Encouragement Program in Nigeria | July 1, 2018 | February 20, 2020 |
| NCT03891758 | Completed | Phase 3 | Confirmatory Study of BK1310 in Healthy Infants | April 1, 2019 | August 10, 2020 |
| NCT03909126 | Completed | Phase 4 | Pertussis Vaccination in Pregnant Women | June 1, 2019 | May 30, 2021 |
| NCT03931239 | Completed | N/A | The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks | March 1, 2018 | July 30, 2018 |
| NCT03942406 | Completed | Phase 2 | Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults | June 15, 2019 | June 24, 2020 |
| NCT03950986 | Completed | N/A | Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System | October 15, 2018 | June 30, 2019 |
| NCT04099303 | Completed | Phase 1 | Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . | April 28, 2020 | November 25, 2021 |
| NCT04102137 | Completed | 3-year Follow-up After a Single Dose Acellular Pertussis Vaccination | June 26, 2018 | August 27, 2018 | |
| NCT04113655 | Completed | 2-year Follow-up After a Single Dose Acellular Pertussis Vaccination | June 20, 2017 | July 31, 2017 | |
| NCT04177485 | Completed | N/A | Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda | February 1, 2016 | December 4, 2017 |
| NCT04529720 | Completed | 5-year Follow-up After a Single Dose Acellular Pertussis Vaccination | August 24, 2020 | November 3, 2021 | |
| NCT04543669 | Completed | Phase 4 | Adacel® Booster Vaccination for CMI Assay Development | July 12, 2017 | September 20, 2017 |
| NCT04589312 | Completed | Phase 2 | Maternal Pertussis Wholecell Responses | October 21, 2020 | June 30, 2023 |
| NCT00343421 | Completed | Phase 3 | Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers | July 2006 | June 2009 |
| NCT00343889 | Completed | Phase 3 | Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine | August 2006 | April 2008 |
| NCT00347958 | Completed | Phase 4 | Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine | August 2006 | October 2008 |
| NCT00348881 | Completed | Phase 3 | Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants | June 2006 | June 2008 |
| NCT00355121 | Completed | Phase 2 | Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® | October 2006 | July 2009 |
| NCT00362336 | Completed | Phase 3 | Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV | August 2006 | August 2009 |
| NCT00362427 | Completed | Phase 2 | Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® | August 2006 | March 2009 |
| NCT00401531 | Completed | Phase 3 | Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants | October 2006 | August 2008 |
| NCT00404651 | Completed | Phase 3 | Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants | November 2006 | July 2008 |
| NCT00432042 | Completed | Phase 3 | Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) | January 12, 2007 | March 27, 2008 |
| NCT00453570 | Completed | Phase 3 | Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months | March 2007 | January 2009 |
| NCT00457249 | Completed | Phase 4 | A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older | March 2007 | November 2008 |
| NCT00467519 | Completed | Phase 3 | Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age | April 2007 | December 2009 |
| NCT00469274 | Completed | N/A | Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure | May 2007 | December 2009 |
| NCT00514059 | Completed | Phase 4 | Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine | April 2007 | June 2007 |
| NCT00514709 | Completed | Phase 3 | Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants | September 2007 | April 2009 |
| NCT00518180 | Completed | Phase 3 | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | July 2007 | October 2008 |
| NCT00524732 | Completed | Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age | September 2004 | September 2005 | |
| NCT00534833 | Completed | Phase 3 | Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ | September 2007 | March 2009 |
| NCT00617812 | Completed | Phase 4 | Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine | March 2008 | May 2009 |
| NCT00619502 | Completed | Phase 3 | Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants | December 2007 | July 2008 |
| NCT00654901 | Completed | Phase 3 | Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ | March 2008 | July 2009 |
| NCT00674908 | Completed | Phase 4 | Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine | March 2008 | May 2009 |
| NCT00707148 | Completed | Phase 1 | Pertussis Vaccine in Healthy Pregnant Women | January 2009 | May 2012 |
| NCT00712959 | Completed | Phase 4 | Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose | June 2008 | December 2009 |
| NCT00772369 | Completed | Retrospective Survey of Safety of Fourth Dose Pentacel® in Children | September 2003 | April 2005 | |
| NCT00772928 | Completed | Phase 3 | Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ | October 2003 | November 2006 |
| NCT00777257 | Completed | Phase 4 | Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine | April 2005 | September 2007 |
| NCT00797511 | Completed | Phase 3 | Immunogenicity and Safety of Adacel Polio Vaccine | November 2008 | July 2009 |
| NCT00802867 | Completed | Phase 4 | Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ | February 2004 | September 2005 |
| NCT00804284 | Completed | Database Surveillance Safety Study of PENTACEL® Vaccine | September 2008 | January 2015 | |
| NCT00828555 | Completed | Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting | November 2008 | February 2012 | |
| NCT00831311 | Completed | Phase 2 | Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants | October 2004 | March 2007 |
| NCT00831753 | Completed | Phase 3 | Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants | May 2008 | November 2009 |
| NCT00855855 | Completed | Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease | February 2009 | December 2014 | |
| NCT01031303 | Completed | Phase 4 | Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age | December 2009 | January 2011 |
| NCT01040052 | Completed | Phase 3 | A Study to Assess the Safety of Adacel® Vaccine | December 2009 | April 2010 |
| NCT01062477 | Completed | Phase 3 | A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants | January 2010 | December 2011 |
| NCT01129362 | Completed | Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines | February 8, 2010 | December 30, 2014 | |
| NCT01137435 | Completed | Phase 4 | Post Marketing Surveillance for ADACEL™ in South Korea | June 2010 | September 2016 |
| NCT01188512 | Completed | Phase 1 | First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine | August 2010 | January 2012 |
| NCT01214889 | Completed | Phase 3 | Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. | September 2010 | December 2011 |
| NCT01233401 | Completed | Tdap Vaccination for Infant Caregivers | June 2010 | June 2011 | |
| NCT01249183 | Completed | Phase 3 | Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old | October 2010 | September 2011 |
| NCT01267058 | Completed | Phase 3 | Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults | September 1997 | February 1998 |
| NCT01287949 | Completed | Phase 3 | Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older | January 2011 | May 2012 |
| NCT01311557 | Completed | Phase 4 | Study of Adacel® Vaccine Administered to Persons 10 Years of Age | March 2011 | January 2012 |
| NCT01346293 | Completed | Phase 3 | Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age | April 2011 | September 2013 |
| NCT01357720 | Completed | Phase 4 | Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination | May 2011 | September 2011 |
| NCT01362517 | Completed | Phase 3 | Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B | April 2010 | April 2011 |
| NCT01437423 | Completed | Phase 4 | Regulatory Post-Marketing Surveillance Study for TETRAXIM™ | June 2011 | November 2015 |
| NCT01439165 | Completed | Phase 4 | Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose | November 2011 | February 2017 |
| NCT01457495 | Completed | Phase 2 | Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly | September 1998 | September 1999 |
| NCT01457508 | Completed | Phase 3 | Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately | January 1999 | March 2000 |
| NCT01470287 | Completed | Phase 3 | Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age | December 2011 | April 2012 |
| NCT01491087 | Completed | Phase 4 | Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China | December 2011 | December 2012 |
| NCT01529645 | Completed | Phase 1 | Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years | March 2012 | July 2013 |
| NCT01597687 | Completed | N/A | Pertussis Infection in Adolescents and Adults With Prolonged Cough | June 20, 2012 | May 2, 2013 |
| NCT01629589 | Completed | Phase 4 | Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents | June 2012 | June 2013 |
| NCT01659996 | Completed | Phase 4 | Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age | July 2012 | September 2015 |
| NCT01689324 | Completed | Phase 1/Phase 2 | Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents | September 2012 | May 2013 |
| NCT01698346 | Completed | Phase 4 | Pertussis (Tdap) Vaccination in Pregnancy | February 2012 | December 2016 |
| NCT01706224 | Completed | Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals | November 2012 | May 2013 | |
| NCT01711645 | Completed | Phase 4 | Tdap Vaccine in Post-Partum Women | October 26, 2012 | August 28, 2015 |
| NCT01761799 | Completed | N/A | Protecting Pregnant Women From Infectious Diseases | December 2012 | August 2015 |
| NCT01878435 | Completed | N/A | Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya | October 2013 | February 2016 |
| NCT01890447 | Completed | Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation | January 2015 | February 2016 | |
| NCT01917357 | Completed | Phase 3 | A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject | September 2013 | April 2014 |
| NCT01933776 | Completed | Phase 1 | Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China | August 2013 | January 2014 |
| NCT01979588 | Completed | N/A | How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice | November 2013 | November 2014 |
| NCT01984125 | Completed | N/A | Testing the Use of Prompts to Increase Adolescent Immunization Rates | April 2011 | December 2013 |
| NCT01993173 | Completed | Phase 3 | Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. | November 2013 | April 2015 |
| NCT02014519 | Completed | N/A | A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary | April 24, 2014 | April 24, 2015 |
| NCT02040636 | Completed | Phase 2 | Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis | January 1999 | May 2000 |
| NCT02089347 | Completed | Phase 3 | Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old | March 2014 | March 2015 |
| NCT02094833 | Completed | Phase 3 | DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants | March 2014 | November 2016 |
| NCT02096276 | Completed | Boostrix® Pregnancy Registry | March 31, 2014 | August 2, 2019 | |
| NCT02118961 | Completed | Phase 3 | Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents | April 2014 | August 2014 |
| NCT02209623 | Completed | TDAP Safety in Pregnant Women | May 2014 | December 18, 2017 | |
| NCT02274285 | Completed | Phase 3 | DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants | October 2014 | May 28, 2016 |
| NCT02301702 | Completed | Phase 2 | Maternal Tdap Immunization in Guatemala | July 2016 | August 13, 2019 |
| NCT02382913 | Completed | Phase 1 | Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) | April 2015 | June 2015 |
| NCT02408926 | Completed | Phase 4 | Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand | April 2015 | August 2018 |
| NCT02428491 | Completed | Phase 3 | Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth | April 20, 2015 | January 11, 2017 |
| NCT05856396 | Not yet recruiting | Phase 4 | Maternal Determinants of Infant Immunity to Pertussis | June 1, 2023 | December 2025 |
| NCT05952596 | Not yet recruiting | Phase 1 | A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults | July 17, 2023 | March 31, 2024 |
| NCT05457946 | Not yet recruiting | Phase 2/Phase 3 | Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series | April 1, 2023 | September 30, 2025 |
| NCT06114160 | Not yet recruiting | Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy | December 1, 2023 | May 1, 2024 | |
| NCT06184542 | Recruiting | Phase 1 | Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine | December 23, 2023 | November 1, 2026 |
| NCT05136599 | Recruiting | Phase 1 | Establishing a Controlled Human Infection Model of Bordetella Pertussis | January 28, 2022 | January 2025 |
| NCT06056050 | Recruiting | Phase 1 | A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) | December 6, 2023 | February 28, 2025 |
| NCT06286007 | Recruiting | Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control | December 21, 2023 | July 1, 2026 | |
| NCT03084614 | Terminated | CD8 Reactivity to Microorganisms in Blood and Breast Milk | March 28, 2017 | November 8, 2019 | |
| NCT04793620 | Terminated | Phase 1 | Pertussis Acellular Vaccine Adjuvanted With TQL1055 | April 6, 2021 | February 14, 2022 |
| NCT04779853 | Unknown status | Seroprevalence of Pertussis Among Healthy Children and Adolescents in Kazakhstan | January 25, 2021 | July 5, 2022 | |
| NCT02511327 | Unknown status | Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants | January 2015 | ||
| NCT00336115 | Unknown status | Phase 4 | The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients | July 2006 | May 2008 |
| NCT03982732 | Unknown status | Maternal Antibody in Milk After Vaccination | August 7, 2018 | October 31, 2019 | |
| NCT04023929 | Unknown status | Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays | October 28, 2020 | September 21, 2021 | |
| NCT04056728 | Unknown status | Phase 4 | A Phase IV Study to Assess the Safety of EupentaTM Inj | September 23, 2019 | December 31, 2020 |
| NCT04073459 | Unknown status | Phase 2 | Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants | November 2019 | August 2020 |
| NCT03341195 | Unknown status | N/A | Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan | January 2018 | September 2018 |
| NCT05193734 | Unknown status | Phase 2/Phase 3 | Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines | February 7, 2022 | March 30, 2023 |
| NCT02257645 | Unknown status | Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks | March 2015 | September 2016 | |
| NCT03606096 | Unknown status | Phase 4 | Gambia Pertussis Study (GaPs) | January 23, 2019 | December 2022 |
| NCT04618640 | Unknown status | Phase 3 | To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years | December 26, 2019 | July 30, 2021 |
| NCT04694430 | Unknown status | A Multi-center Study to Determine the Prevalence and Influence of Pertussis on COPD Exacerbation in Shenzhen | January 1, 2021 | December 31, 2021 | |
| NCT04694963 | Unknown status | A Multi-center Study to Determine the Prevalence and Influence of Pertussis on Subacute Cough in Shenzhen | January 1, 2021 | December 31, 2021 | |
| NCT03908164 | Unknown status | Phase 4 | Optimising the Timing of Whooping Cough Immunisation in MUMs | May 7, 2019 | May 2021 |
| NCT00870350 | Unknown status | Phase 4 | An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster | April 2009 | June 2010 |
| NCT00877357 | Unknown status | Phase 4 | Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine | January 2009 | February 2013 |
| NCT00932269 | Unknown status | Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease | March 2007 | September 2011 | |
| NCT04535505 | Withdrawn | Pathogenic Bordetella Rapid Detection | July 2022 | December 2022 | |
| NCT01003431 | Withdrawn | Phase 3 | A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) | December 2009 | September 2010 |
- Disase is a (Disease Ontology)
- DOID:0050339
- Cross Reference ID (Disease Ontology)
- KEGG:05133
- Cross Reference ID (Disease Ontology)
- MESH:D001885
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:26484003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0006015
- Exact Synonym (Disease Ontology)
- bordetella infection
- Exact Synonym (Disease Ontology)
- WC - Whooping cough
- Exact Synonym (Disease Ontology)
- whooping cough